When should I cite TRI?
Projects, publications, patents, grants, presentations or other outcomes resulting from research supported in whole or part by a Translational Research Institute (TRI) resource or service are required to:
- Acknowledge the TRI by citing the appropriate grant(s).
- Ensure publications are submitted to PubMed Central and assigned a PMCID. Instructions and assistance for obtaining a PMCID are available at the bottom of the page.
- Notify TRI by filling out our Citation Reporting Form.
What constitutes TRI support?
Examples of TRI support include but are not limited to the following:
- Research financed in whole or part by the TRI. This includes funding from TRI’s Pilot Award Program
- Receipt of a KL2 Scholar Award
- Receipt of a Western States Consortium Pilot Award
- Use of electronic health care data and related services, including the Arkansas Clinical Data Repository, Informatics for Integrating Biology and the Bedside (i2b2), Honest Broker System and LifeLink™ Health Claims database
- Informatics or data collection support, including use of UAMS’ Comprehensive Research Informatics Suite
- Consultation regarding research design, biostatistics, ethics, community engagement, etc.
- Guidance or mentorship from TRI personnel
Which award numbers should I use?
When citing TRI related awards, you should cite all award numbers under which you have received TRI’s monetary support. Support is determined by the date of award. Multi-year awards should cite award numbers that correspond with both the initial notice of award date and any subsequent funding years. For example, an awardee who received year one of funding in 2016 and year two in 2017 would need to cite both UL1 TR000039 and U54 TR001629. We also ask that you to cite TRI’s current U grant number (UL1 TR003107 until 6/30/2024). If you have any questions about what constitutes support, when your support started, or which grants you should cite, please contact Robin Liston.
Please use this table to identify which award number(s) you should cite.
| Sponsor | Start Date | End Date | Award ID |
|---|---|---|---|
| NCRR | 7/14/2009 | 3/31/2012 | UL1 RR029884 |
| NCRR | 7/14/2009 | 3/31/2012 | KL2 RR029883 |
| NCATS | 4/1/2012 | 3/31/2016 | UL1 TR000039 |
| NCATS | 4/1/2012 | 3/31/2016 | KL2 TR000063 |
| NCATS | 9/26/2017 | 8/31/2019 | U54 TR001629 |
| NCATS | 7/1/2019 | 6/30/2024 | UL1 TR003107 |
| NCATS | 7/1/2019 | 6/30/2024 | KL2 TR003108 |
| NCATS | 7/1/2019 | 6/30/2024 | TL1 TR003109 |
CITE TRI Campaign pdf download
Suggested Language
You can use the language below when citing TRI.
“The project described was supported by the Translational Research Institute (TRI), grant [insert appropriate award number(s)] through the National Center for Advancing Translational Sciences of the National Institutes of Health (NIH). The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH.”
NIH Public Access Policy
An important part of citing TRI is ensuring that your cited manuscripts are compliant with the NIH’s Public Access Policy.
From the NIH Website: SEC. 218. The Director of the National Institutes of Health shall require that all investigators funded by the NIH submit or have submitted for them to the National Library of Medicine’s PubMed Central an electronic version of their final peer-reviewed manuscripts upon acceptance for publication, to be made publicly available no later than 12 months after the official date of publication: Provided, That the NIH shall implement the public access policy in a manner consistent with copyright law.
This regulation applies to any publication which cites TRI. Authors are responsible for ensuring that this process is completed and that your TRI cited manuscripts are compliant. If you need assistance, we have a tutorial and a step-by-step guide available through the links below. You can also contact Robin Liston for assistance and questions.
When and How to Comply (NIH Website)
Public Access Policy Guide (written by Robin Liston)
Public Access Policy Tutorial (Feb 4, 2021- Robin Liston)- Slides (video of the presentation is below)
